Advocacy intelligence hub — real-time data for patient organizations
Memorial Sloan Kettering Cancer Center — PHASE1, PHASE2
Orca Biosystems, Inc. — PHASE2
Ossium Health, Inc. — PHASE1, PHASE2
Federal Research Institute of Pediatric Hematology, Oncology and Immunology — PHASE2, PHASE3
Imperial College London — PHASE2
Senti Biosciences — PHASE1
St. Jude Children's Research Hospital — PHASE1
Medical College of Wisconsin — NA
Andrew E. Place, MD — PHASE1
Fred Hutchinson Cancer Center — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Zachariah DeFilipp, MD, M.D
Masachusetts General Hospital
📍 ATLANTA, GA
Olivier Hermine, MD
Assistance Publique - Hôpitaux de Paris
Tapan M Kadia
M D Anderson Cancer Center
📍 Houston, Texas
Brigitte C. Widemann, MD, M.D
National Cancer Institute (NCI)
📍 BETHESDA, MD
Kyoo H. Lee, MD
Asan Medical Center
Elias Jabbour, M.D
M.D. Anderson Cancer Center
📍 HOUSTON, TX